MONDAY, April 14, 2014 (HealthDay News) -- Boys with autism were
three times more likely to have been exposed to antidepressants
known as SSRIs in the womb than typically developing children,
according to new research.
The new study also found that boys whose mothers took SSRIs --
drugs including Celexa, Lexapro, Paxil, Prozac and Zoloft -- during
pregnancy were also more likely to have developmental delays.
Results of the study were published online April 14 and in the
May print issue of
"We found prenatal SSRI exposure was almost three times as likely in boys with autism spectrum disorders relative to typical development, with the greatest risk when exposure is during the first trimester," said study co-author Li-Ching Lee, an associate scientist in the department of epidemiology at Johns Hopkins Bloomberg School of Public Health, in Baltimore.
While the study found an association between prenatal use of
SSRI antidepressants and autism risk in boys, it did not prove
The study authors were quick to point out that there are risks
to both the mother and fetus from untreated depression.
"It's a complex decision whether to treat or not treat depression with medications during pregnancy," Lee said. "There are so many factors to consider. We didn't intend for our study to be used as a basis for clinical treatment decisions. Women should talk with their doctors about SSRI treatments."
Other experts said the overall risk of having a child with
autism remains very low.
SSRIs used during pregnancy cross the placenta and increase
levels of the hormone serotonin in the fetus, as they do in the
mother, the researchers said. Higher serotonin levels decrease
depression, and these antidepressants are used in about 4 percent
of all pregnancies, according to background information with the
About one in three children with autism has higher-than-normal
serotonin levels. Researchers think these high levels may lead to
the development of abnormal brain circuitry, which may play a role
in the development of some autism symptoms, according to the study
The new study is the latest in an ongoing debate about SSRI use
during pregnancy and its possible association to autism spectrum
disorders. Other studies on SSRI use in pregnancy have produced
One study published in the November 2011
Archives of General Psychiatrythat included nearly 300
children with autism spectrum disorders found double the risk of
autism when the mother had used SSRIs, with a stronger link to SSRI
use during the first trimester.
Another study, published in the Dec. 19, 2013
New England Journal of Medicine, included almost 4,000
children with autism spectrum disorders. This study didn't find a
significant association between autism and SSRI exposure during
The current study included 966 mother-child pairs. Nearly 800
children were male. The average age of the children at the time of
the study was nearly 4 years. About 500 of the children had an
autism spectrum disorder, 154 had some type of developmental delay
and 320 were typically developing children.
SSRI exposure was lowest in the typically developing children,
with just 3.4 percent exposed during pregnancy. For those with
autism, SSRI exposure occurred in 5.9 percent of pregnancies and
SSRI exposure occurred in 5.2 percent of pregnancies for children
with developmental delays.
When the researchers looked at boys and girls together, there
was a trend toward a higher risk of autism and developmental delay.
Lee noted that most of the study children were male, and said that
they'd need a larger sample with more girls to get a better idea of
the overall risk.
However, when the researchers separated the data on boys and
girls, they found that boys with autism were three times more
likely to have been exposed to SSRIs in pregnancy, and the rate was
highest for those exposed during the first trimester, according to
The study authors also found that boys with developmental delays
were three to five times more likely to have been exposed to SSRIs
during pregnancy compared to typically developing children. Rates
were highest with exposure during the third trimester.
"This study suggests that there are some risks associated with SSRI exposure and that the risk is higher in boys. They [the study authors] also found the risk is highest with exposure during the first trimester when early brain development is occurring," said Dr. Eric Hollander, director of the autism and obsessive-compulsive disorder program at Montefiore Medical Center, in New York City.
Hollander noted that even if other research confirms the much
higher risk for boys after SSRI exposure, women should know the
risk is still low. "If the risk of autism is around 1 percent now,
and you raise it to 3 percent, that still means that 97 percent of
the time, you won't have an autism spectrum disorder. The chances
are still overwhelming that they won't have a child with an autism
spectrum disorder," he said.
Reproductive psychiatrist Dr. Ariela Frieder, also from
Montefiore Medical Center, said this study's findings won't change
her clinical practice.
"[This study] shows an association between the use of SSRIs and autism spectrum disorders. However, association does not mean causation, and this is very important for women to understand," she said.
Dr. Eyal Shemesh, chief of behavioral and developmental health
in the department of pediatrics at the Mount Sinai Kravis
Children's Hospital, in New York City said: "It's very hard to do a
definitive study of this. The confounders here are huge. They [the
study authors] initially found no difference between the groups --
it was only when they looked specifically at gender-adjusted
differences that they saw an association. We still don't know
whether SSRIs are associated with more autism. We need to look
Shemesh added: "The one thing we really know with certainty is
that depression is not good for pregnancy. Women who are depressed
have bad outcomes and their kids don't do well. We need to treat
depression, and there are psychotherapy options and medication
options. You need to make a reasoned decision with your doctor. I
would be very concerned about any woman just stopping her
Montefiore's Frieder agreed that untreated depression is a
serious risk, and recommended that women discuss the choice with
their doctor and have an individualized risk/benefit
A report from the U.S. Centers for Disease Control and
Prevention last month said that one in 68 American children is now
diagnosed with autism or a related disorder, which is a 30 percent
increase from just two years ago when the estimate was one in 88
Learn more about depression in pregnancy from the
U.S. Office on Women's Health.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.